Abstract Submission Guidelines for General Attendants

General Information The first author must be the presenting author. Registration of the first author is required for abstract submission. A participant may be first author of only one abstract.There is no limit on co-authorship on other abstracts. Please indicate the subject code on the abstract form. Please fill out the abstract form completely. Please inform the Secretariat of Conference immediately if the presenting author cannot attend the Conference. Abstracts not following the Guidelines will not be accepted. Abstracts containing only results or studies that have been published or that will be published by January 31, 2010 will not be accepted. The deadline for abstract submission is January 31, 2010. All abstracts will be reviewed by the Scientific Program Committee.Acceptance and presentation assignment of the abstract will be announced around the end of February, 2010.All accepted papers will be published in the program book of the Conference. Subject code C1 - Population Genetics C2 - Clinical Genetics C3 - Genetic Therapeutics C4 - Prenatal and Pre-implantation Diagnosis & Screening C5 - Pharmacogenetics C6 - Medical Genetics C7 - Molecular Genetics C8 - Genomic Technologies in the Post Genomic Era C9 - Cancer Genetics and Genomics C10 - Complex Disorders Abstract Preparation The abstract should be in English, typed, and single-spaced using Times New Roman font at size 11.The entire abstract should fit within the box provided in the abstract form. The title should be in BOLD letters. The full name (first, middle initial, and last), affiliation, and country of each author should be indicated. The name of the presenting author should be underlined. Do not indent paragraphs. Skip a line between paragraphs. Sample abstract A prospective study of HLA-B*1502 genotyping in preventing carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis Pei Chen1, Chen-Yang Shen1, Juei-Jueng Lin2, Cheung-Ter Ong3, Shey-Lin Wu4, Yuan-Tsong Chen1, and Taiwan SJS consortium. 1Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; 2Chu Shang Show Chwan Hospital, Nan-tou, Taiwan; 3Chia-Yi Christian Hospital, Chia-Yi, Taiwan; 4Changhua Christian Hospital, Chang-Hua, Taiwan. Stevens-Johnson syndrome (SJS) and its related disease toxic epidermal necrolysis (TEN) are two of the most serious adverse reactions caused by drugs. Carbamazepine (CBZ), used primarily in the treatment of epilepsy and bipolar disorder, is the commonest cause of SJS/TEN in Abstract Submission The abstract form can be downloaded from the website of the Conference (http://taiwan-acga2010.ibms.sinica.edu.tw).Save your finished abstract form as a doc. file and email it to the Secretariat of Conference at ACGA2010@mail.tcm-mice.com.tw by January 31, 2010. Abstracts submitted via fax will not be accepted. One can make revision of the abstract by contacting the Secretariat of Conference via email by January 31, 2010.No revision of the abstract will be accepted after January 31, 2010.